Сједињене Америчке Државе - Енглески - NLM (National Library of Medicine)

yiling pharmaceutical, inc. - sildenafil citrate (unii: bw9b0ze037) (sildenafil - unii:3m7ob98y7h) - sildenafil tablets are indicated for the treatment of pulmonary arterial hypertension (who group i) in adults to improve exercise ability and delay clinical worsening. the delay in clinical worsening was demonstrated when sildenafil was added to background epoprostenol therapy [see clinical studies (14)]. studies establishing effectiveness were short-term (12 to16 weeks), and included predominately patients with new york heart association (nyha) functional class ii-iii symptoms and idiopathic etiology (71%) or associated with connective tissue disease (ctd) (25%). sildenafil tablets are contraindicated in patients with: • concomitant use of organic nitrates in any form, either regularly or intermittently, because of the greater risk of hypotension [see warnings and precautions (5.2)]. • concomitant use of riociguat, a guanylate cyclase stimulator. pde5 inhibitors, including sildenafil, may potentiate the hypotensive effects of riociguat. • known hypersensitivity to sildenafil or any compon

Ирска - Енглески - HPRA (Health Products Regulatory Authority)

wockhardt uk limited - heparin sodium - solution injection or concentrate for solution infusion - 1000 international unit(s)/millilitre - heparin group; heparin

Ирска - Енглески - HPRA (Health Products Regulatory Authority)

wockhardt uk limited - heparin sodium - solution injection or concentrate for solution infusion - 1000 international unit(s)/millilitre - heparin group; heparin

Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

heparin sodium -

Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - heparin sodium -

Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

orphan australia pty ltd - treprostinil -

Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - heparin sodium, quantity: 5000 iu/ml - injection, solution - excipient ingredients: water for injections; hydrochloric acid; sodium hydroxide - indications as at 26 november 2001: prophylaxis and treatment of thromboembolic disorders such as thrombophlebitis, pulmonary embolism, coronary or venous thrombosis and occlusive vascular disease. as a low-dose regimen for the prevention of thromboembolic complications arising as a result of cardiac and arterial surgery. as an anticoagulant during blood transfusions, extracorporeal circulation, dialysis and other perfusion techniques and in blood samples for laboratory purposes.

Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - heparin sodium, quantity: 1000 iu/ml - injection, solution - excipient ingredients: water for injections; hydrochloric acid; sodium hydroxide - indications as at 26 november 2001: prophylaxis and treatment of thromboembolic disorders such as thrombophlebitis, pulmonary embolism, coronary or venous thrombosis and occlusive vascular disease. as a low-dose regimen for the prevention of thromboembolic complications arising as a result of cardiac and arterial surgery. as an anticoagulant during blood transfusions, extracorporeal circulation, dialysis and other perfusion techniques and in blood samples for laboratory purposes.

Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

stallergenes australia pty ltd - white shrimp -

Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

stallergenes australia pty ltd - secale cereale -